Below are the most recent publications written about "Neurotransmitter Agents" by people in Profiles.
-
Lai Y, Fois G, Flores JR, Tuvim MJ, Zhou Q, Yang K, Leitz J, Peters J, Zhang Y, Pfuetzner RA, Esquivies L, Jones P, Frick M, Dickey BF, Brunger AT. Inhibition of calcium-triggered secretion by hydrocarbon-stapled peptides. Nature. 2022 03; 603(7903):949-956.
-
Stahl A, Noyes NC, Boto T, Botero V, Broyles CN, Jing M, Zeng J, King LB, Li Y, Davis RL, Tomchik SM. Associative learning drives longitudinally graded presynaptic plasticity of neurotransmitter release along axonal compartments. Elife. 2022 03 14; 11.
-
Prossin A, Koch A, Campbell P, Laumet G, Stohler CS, Dantzer R, Zubieta JK. Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission. Mol Psychiatry. 2022 Feb; 27(2):831-839.
-
Luck B, Horvath TD, Engevik KA, Ruan W, Haidacher SJ, Hoch KM, Oezguen N, Spinler JK, Haag AM, Versalovic J, Engevik MA. Neurotransmitter Profiles Are Altered in the Gut and Brain of Mice Mono-Associated with Bifidobacterium dentium. Biomolecules. 2021 07 23; 11(8).
-
Shakil S, Masjoan Juncos JX, Mariappan N, Zafar I, Amudhan A, Amudhan A, Aishah D, Siddiqui S, Manzoor S, Santana CM, Rumbeiha WK, Salim S, Ahmad A, Ahmad S. Behavioral and Neuronal Effects of Inhaled Bromine Gas: Oxidative Brain Stem Damage. Int J Mol Sci. 2021 Jun 12; 22(12).
-
Sardar D, Lozzi B, Woo J, Huang TW, Cvetkovic C, Creighton CJ, Krencik R, Deneen B. Mapping Astrocyte Transcriptional Signatures in Response to Neuroactive Compounds. Int J Mol Sci. 2021 Apr 12; 22(8).
-
Dono A, Patrizz A, McCormack RM, Putluri N, Ganesh BP, Kaur B, McCullough LD, Ballester LY, Esquenazi Y. Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters. CNS Oncol. 2020 06; 9(2):CNS57.
-
Sarasamma S, Audira G, Siregar P, Malhotra N, Lai YH, Liang ST, Chen JR, Chen KH, Hsiao CD. Nanoplastics Cause Neurobehavioral Impairments, Reproductive and Oxidative Damages, and Biomarker Responses in Zebrafish: Throwing up Alarms of Wide Spread Health Risk of Exposure. Int J Mol Sci. 2020 Feb 19; 21(4).
-
Cai YQ, Hou YY, Pan ZZ. GluA1 in central amygdala increases pain but inhibits opioid withdrawal-induced aversion. Mol Pain. 2020 Jan-Dec; 16:1744806920911543.
-
Solingapuram Sai JKK, Hurley RA, Dodda M, Taber KH. Positron Emission Tomography: Updates on Imaging of Addiction. J Neuropsychiatry Clin Neurosci. 2019 Fall; 31(4):A6-288.